{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:36:56Z","timestamp":1792103816538,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374233"],"award-info":[{"award-number":["82374233"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03646-z","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:38:09Z","timestamp":1738924689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009\u20132024)"],"prefix":"10.1186","volume":"25","author":[{"given":"Minling","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"5","key":"3646_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/sjg.sjg_62_24","volume":"30","author":"A Alqahtani Saleh","year":"2024","unstructured":"Alqahtani Saleh A, Abaalkhail F, Saad A, et al. The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia. Saudi J Gastroenterol. 2024;30(5):310\u20138. https:\/\/doi.org\/10.4103\/sjg.sjg_62_24.","journal-title":"Saudi J Gastroenterol"},{"issue":"1","key":"3646_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12876-024-03350-4","volume":"24","author":"B Nalbant","year":"2024","unstructured":"Nalbant B. Pape Thorben,Schneider Andrea,et al.Clinical significance of transjugular liver biopsy in acute liver failure - a real-world analysis. BMC Gastroenterol. 2024;24(1):252. https:\/\/doi.org\/10.1186\/s12876-024-03350-4.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"3646_CR3","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1111\/liv.15999","volume":"44","author":"X Zhang Qian","year":"2024","unstructured":"Zhang Qian X, Si FL, et al. Long-term risk of cardiovascular disease associated with MASLD and different cardiometabolic risk factors in IBD patients: a prospective cohort study. Liver Int. 2024;44(9):2315\u201328. https:\/\/doi.org\/10.1111\/liv.15999.","journal-title":"Liver Int"},{"key":"3646_CR4","unstructured":"Li R, Xujun LHY et al. Metabolic dysfunction-associated Steatotic Liver Disease is becoming the leading driver of the Burden of cirrhosis in China: results from the global burden of Disease Study 2019. J Clin Gastroenterol 202410.1097\/MCG.0000000000002055"},{"key":"3646_CR5","doi-asserted-by":"publisher","unstructured":"Shan H, Yiwei H, Lei S et al. Prevalence and risk factors of significant fibrosis in CHB patients with concurrent MASLD.Annals of Hepatology.2024: 101589.https:\/\/doi.org\/10.1016\/j.aohep.2024.101589","DOI":"10.1016\/j.aohep.2024.101589"},{"key":"3646_CR6","doi-asserted-by":"publisher","unstructured":"Wang Tongtong X, Yuzhi R, Annaswamy et al. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: an updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011\u20132018.Annals of Hepatology.2024;29 (1): 101154.https:\/\/doi.org\/10.1016\/j.aohep.2023.101154","DOI":"10.1016\/j.aohep.2023.101154"},{"key":"3646_CR7","unstructured":"Kong Qingyan G, Qianqian L. Wenjie, Tenofovir versus entecavir on long-term prognosis in hepatocellular carcinoma patients with concurrent metabolic dysfunction-associated steatotic liver disease and hepatitis B.Asian. J Surg 202410.1016\/j.asjsur.2024.03.147"},{"issue":"11","key":"3646_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.14218\/JCTH.2024.00287","volume":"12","author":"J Jiang","year":"2024","unstructured":"Jiang J. Shi Meifeng,Wu Shuduo,et al. A case of severe cholestatic Hepatitis Induced by a Novel Dual Agonist of Glucagon-like Peptide-1 and glucose-dependent Insulinotropic polypeptide receptors. J Clin Translational Hepatol. 2024;12(11):949\u201354. https:\/\/doi.org\/10.14218\/JCTH.2024.00287.","journal-title":"J Clin Translational Hepatol"},{"key":"3646_CR9","unstructured":"Patel Nishi H, Lucko Aaron V, Alicia et al. Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease. J Viral Hepat 202410.1111\/jvh.13979"},{"key":"3646_CR10","doi-asserted-by":"publisher","unstructured":"Han Jiaxin K, Wentao Y, Liu, et al. Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma. Cancer Biology Med. 2024;21(9). https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0048.","DOI":"10.20892\/j.issn.2095-3941.2024.0048"},{"key":"3646_CR11","doi-asserted-by":"publisher","unstructured":"Lin Ming G, Bowen P, Mengnan et al. Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study.Frontiers in physiology.2024;15: 1347459.https:\/\/doi.org\/10.3389\/fphys.2024.1347459","DOI":"10.3389\/fphys.2024.1347459"},{"key":"3646_CR12","doi-asserted-by":"publisher","unstructured":"Huang S-C, Tung-Hung S, Tai-Chung T et al. Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic Hepatitis B.American journal of gastroenterology.2024.https:\/\/doi.org\/10.14309\/ajg.0000000000002915","DOI":"10.14309\/ajg.0000000000002915"},{"key":"3646_CR13","doi-asserted-by":"publisher","unstructured":"Con Danny T, Steven C-C, Daniel et al. Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on serial non-invasive fibrosis markers in Chronic Hepatitis B.Digestive diseases and sciences.2024;69 (4): 1496\u2013506.https:\/\/doi.org\/10.1007\/s10620-024-08354-4","DOI":"10.1007\/s10620-024-08354-4"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03646-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03646-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:38:13Z","timestamp":1738924693000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03646-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3646"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03646-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the initial liver biopsy study (approval no. B201308702), ethics approval was granted by the Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine. Informed consent was obtained from all participants at that time. Authors reporting experiments on humans and\/or the use of human tissue samples must confirm that all experiments were performed in accordance with relevant guidelines and regulations. In June 2023, our center began planning to conduct a large-scale retrospective analysis within a two-year period. Regarding the current retrospective follow-up study, the same Ethics Committee granted a rapid ethical review (approval no. ZE202319401, valid until June 2025), as it did not involve any additional interventions or risks to the participants. We assure the integrity and confidentiality of the data and adhere to ethical guidelines. Requests for data access will undergo review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}